GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OncoSil Medical Ltd (ASX:OSL) » Definitions » Shares Buyback Ratio %

OncoSil Medical (ASX:OSL) Shares Buyback Ratio % : -120.34 (As of Apr. 13, 2025)


View and export this data going back to 2005. Start your Free Trial

What is OncoSil Medical Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. OncoSil Medical's current shares buyback ratio was -120.34%.


OncoSil Medical Shares Buyback Ratio % Historical Data

The historical data trend for OncoSil Medical's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSil Medical Shares Buyback Ratio % Chart

OncoSil Medical Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.81 3.77 -22.81 -61.96 -59.27

OncoSil Medical Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 -61.47 0.07 -59.38 -38.25

OncoSil Medical Shares Buyback Ratio % Calculation

OncoSil Medical's Shares Buyback Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2023 ) - Shares Outstanding (EOP) (A: Jun. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2023 )
=(2092.067 - 3332.110) / 2092.067
=-59.27%

OncoSil Medical's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(3332.110 - 4606.580) / 3332.110
=-38.25%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoSil Medical Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of OncoSil Medical's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoSil Medical Business Description

Traded in Other Exchanges
N/A
Address
7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

OncoSil Medical Headlines

No Headlines